Tizanidine Tablet
Product Images NDC 68788-8802
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-8802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)
Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)
Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)
This text mentions the improvement in Ashworth Score, with a mean dose of 26.8 mg. It also references the end of titration in study week 3, end of maintenance in study week 7, and the use of Last Observation Carried Forward as an endpoint. The document seems to be related to a study or clinical trial evaluating the impact of a particular treatment.*
Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)
Tizanidine Tablets Usp 4mg (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 07)
This description helps identify Tizanidine Tablets, which are a generic version of Zanaflex. Each tablet contains 4mg of tizanidine base. These tablets should be stored at 20°- 25°C (68°- 77°F) and kept out of reach of children. The manufacturer is Unichem Laboratories Ltd. The tablets are white, round, multi-scored, and imprinted with U 169. They may cause drowsiness, and dosage instructions should be followed carefully. It is important to note that federal law prohibits transferring this medication to anyone other than the patient for whom it was prescribed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.